CONTACT
+91 80 2808 2808
info@biocon.com

Press Releases

Biocon  /  News – Posts  /  Press Releases

Biocon expands generic formulations portfolio with the launch of Tacrolimus capsules in the US

Biocon expands generic formulations portfolio with the launch of Tacrolimus capsules in the US
  • Mon, 28-Dec-2020
  • Posted by: BIOCON
No Comments

Biocon Biologics signs an MoU with CSSC in Tanzania for Mission 10 cents

Biocon Biologics signs an MoU with CSSC in Tanzania for Mission 10 cents
  • Tue, 15-Dec-2020
  • Posted by: BIOCON
No Comments

Biocon Biologics Receives USD 150 Million Capital Injection from Goldman Sachs
  • Sat, 07-Nov-2020
  • Posted by: BIOCON
No Comments

Biocon Ranked Among Top 5 Biotech Employers Globally
  • Fri, 30-Oct-2020
  • Posted by: BIOCON
No Comments

Biocon Q2FY21 Revenue at Rs 1,760 Cr, Up 10%; EBITDA at Rs 407 Cr; Net Profit (before exceptional item & discontinuing operations) at Rs 174 Cr; Generics Up 8% at Rs 599 Cr; Biosimilars Up 11% at Rs 676 Cr; Research Services Up 12% at Rs 520 Cr.
  • Fri, 23-Oct-2020
  • Posted by: BIOCON
No Comments

Biocon Foundation Signs MoU with Bangalore Metro to Contribute Towards Building Metro Station in Hebbagodi
  • Thu, 08-Oct-2020
  • Posted by: BIOCON
No Comments

Biocon Biologics to Roll Out ‘Mission 10 cents’ in Philippines; Signs MoU with 2 Municipal Governments & reach52 to enable Affordable Access to Quality Insulins
  • Wed, 30-Sep-2020
  • Posted by: BIOCON
No Comments

Biocon appoints Anupam Jindal as its Chief Financial Officer
  • Tue, 22-Sep-2020
  • Posted by: BIOCON
No Comments

Biocon Biologics and Mylan Announce Launch of Semglee™ (insulin glargine injection) in the U.S. to Expand Access for Patients Living with Diabetes
  • Mon, 31-Aug-2020
  • Posted by: BIOCON
No Comments

Tata Capital Growth Fund to Invest ~USD 30 million (Rs 225 Crore) in Biocon Biologics for an Equity Stake of 0.85% Deal Values Biocon Biologics at USD 3.5 Billion.
  • Fri, 31-Jul-2020
  • Posted by: BIOCON
No Comments

Report adverse event/ side effects and/or product complaints for Biocon products.


Click here to report adverse event/side effects/product complaints and/or submit medical queries for Biocon Biologics Limited & BBL Affiliate products.

Click here to report adverse event/side effects/product complaints and/or post medical queries for Biocon Limited, Biocon Pharma Limited, Biocon Pharma Inc., Biocon Pharma UK Limited, Biocon Pharma Malta Ltd and Biocon FZ LLC products.





* Safe Harbour | Privacy Policy | Terms of Use © 2024, Biocon. All Rights Reserved
Share
Leaving the Biocon site!

You are now leaving the Biocon website for a Biocon affiliate site or third party site that is solely responsible for its content, including its compliance with guidelines applicable in certain geographies. Links to Biocon affiliate sites and third party sites are provided as a resource to our visitors and may not be governed by the same regulatory requirements applicable to this site and unaffiliated third party sites are subject to their own terms and data protection notices and practices. Moreover, if their third party site is subject to other country laws, regulatory requirements, data protection requirements or medical practices may differ between countries and the information provided therein may not be suitable for use in your country.

Agree >>